• 1
    Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010;121:e46-e215.
  • 2
    Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106:3143-3421.
  • 3
    Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
  • 4
    Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis 2002;165:285-292.
  • 5
    Flint AJ, Hu FB, Glynn RJ, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) 2010;18:377-383.
  • 6
    Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88-107.
  • 7
    National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. Obes Res 1998;6 (Suppl 2):51S-209S.
  • 8
    Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
  • 9
    Finkelstein EA, DiBonaventura M, Burgess SM, Hale BC. The costs of obesity in the workplace. J Occup Environ Med 2010;52:971-976.
  • 10
    Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood) 2003;Suppl Web Exclusives:W3-219-W3-226.
  • 11
    Finkelstein E, Fiebelkorn C, Wang G. The costs of obesity among full-time employees. Am J Health Promot 2005;20:45-51.
  • 12
    Gates DM, Succop P, Brehm BJ, Gillespie GL, Sommers BD. Obesity and presenteeism: the impact of body mass index on workplace productivity. J Occup Environ Med 2008;50:39-45.
  • 13
    Said Q, Marx CM, Schwartz JS, Ben-Joseph R, Brixner DI. Impact of body mass index on the incidence of cardiometabolic risk factors in ambulatory care settings over 5 years or more. Value Health 2010;13:265-272.
  • 14
    Brixner D, Ghate SR, McAdam-Marx C, Ben-Joseph R, Said Q. Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database. J Manag Care Pharm 2008;14:756-767.
  • 15
    Nguyen NT, Nguyen XM, Wooldridge JB, Slone JA, Lane JS. Association of obesity with risk of coronary heart disease: findings from the National Health and Nutrition Examination Survey, 1999-2006. Surg Obes Relat Dis 2010;6:465-469.
  • 16
    Palmer J, Kalsekar A, Boye K, Goodall G. The impact of obesity on adverse cardiovascular outcomes in the general population and in patients with type 2 diabetes. Clin Med Endo 2009;2:43-69.
  • 17
    Malone DC, Boudreau DM, Nichols GA, et al. Association of cardiometabolic risk factors and prevalent cardiovascular events. Metab Syndr Relat Disord 2009;7:585-593.
  • 18
    Duh MS, Fulcher NM, White LA, et al. Costs associated with cardiovascular events in patients with hypertension in US managed care settings. J Am Soc Hypertens 2009;3:403-415.
  • 19
    Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004;47:1747-1759.
  • 20
    Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002;25:1790-1794.
  • 21
    Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-1214.
  • 22
    Boudreau DM, Malone DC, Raebel MA, et al. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord 2009;7:305-314.
  • 23
    Brixner D, Said Q, Kirkness C, Oberg B, Ben-Joseph R, Oderda G. Assessment of cardiometabolic risk factors in a national primary care electronic health record database. Value Health 2007;10( S1):S29-S36.
  • 24
    Orzano AJ, Scott JG. Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract 2004;17:359-369.
  • 25
    Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-1252.
  • 26
    American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010;33 (Suppl 1):S11-S61.
  • 27
    Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US adult population: findings from the national health and nutrition examination survey, 1999-2006. Obes Surg 2011;21:351-355.
  • 28
    Asche CV, Singer ME, Jhaveri M, Chung H, Miller A. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States. J Manag Care Pharm 2010;16:703-712.
  • 29
    Zhao Y, Kuo TC, Weir S, Kramer MS, Ash AS. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's. BMC Health Serv Res 2008;8:108-115.
  • 30
    Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009;28:w822-w831.
  • 31
    Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 2012;125:e2-e220.
  • 32
    Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc 1995;43:329-337.
  • 33
    Oderda G, Lieberman M, Asche CV, Brixner DI, eds. Use of electronic medical record (EMR) data in outcomes research. In: 10th Annual European Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Dublin, Ireland, 2007.